Systemic toxicity related to metal hip prostheses

SM Bradberry, JM Wilkinson, RE Ferner - Clinical toxicology, 2014 - Taylor & Francis
Introduction. One in eight of all total hip replacements requires revision within 10 years, 60%
because of wear-related complications. The bearing surfaces may be made of …

Systemic toxicity eliciting metal ion levels from metallic implants and orthopedic devices–A mini review

RV Badhe, O Akinfosile, D Bijukumar, M Barba… - Toxicology letters, 2021 - Elsevier
The metal/metal alloy-based implants and prostheses are in use for over a century, and the
rejections, revisions, and metal particle-based toxicities were reported concurrently …

Mechanisms of toxic cardiomyopathy

P Hantson - Clinical toxicology, 2019 - Taylor & Francis
Background: Dilated cardiomyopathy is a frequent disease responsible for 40–50% of cases
of heart failure. Idiopathic cardiomyopathy is a primary disorder often related to …

[HTML][HTML] Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria

AC Bay-Jensen, D Reker… - Osteoarthritis and …, 2016 - Elsevier
Objective To review and summarize biomarker data published from April 2014 to May 2015
to provide insight to the ongoing work in the field of osteoarthritis (OA). Furthermore, to …

Cobalt cardiomyopathy: a critical reappraisal in light of a recent resurgence

M Packer - Circulation: Heart Failure, 2016 - Am Heart Assoc
Cobalt can cause a distinctive, rapidly progressive and reversible depression of cardiac
systolic function, which is readily distinguished from other causes of cardiomyopathy …

Pseudotumor formation and serum ions after large head metal-on-metal stemmed total hip replacement. Risk factors, time course and revisions in 706 hips

BH Bosker, HB Ettema, M Van Rossum… - Archives of orthopaedic …, 2015 - Springer
Introduction The incidence and natural course of pseudotumors in metal-on-metal total hip
arthroplasties is largely unknown. The objective of this study was to identify the true …

Interpreting cobalt blood concentrations in hip implant patients

DJ Paustenbach, DA Galbraith, BL Finley - Clinical toxicology, 2014 - Taylor & Francis
Introduction. There has been some recent concern regarding possible systemic health
effects resulting from elevated blood cobalt concentrations in patients with cobalt containing …

Cobalt-induced cardiomyopathy–do circulating cobalt levels matter?

MRJ Jenkinson, RMD Meek, R Tate… - Bone & Joint …, 2021 - boneandjoint.org.uk
Elevated levels of circulating cobalt ions have been linked with a wide range of systemic
complications including neurological, endocrine, and cardiovascular symptoms. Case …

Review of cobalt toxicokinetics following oral dosing: Implications for health risk assessments and metal-on-metal hip implant patients

BE Tvermoes, DJ Paustenbach, BD Kerger… - Critical reviews in …, 2015 - Taylor & Francis
Cobalt (Co) can stimulate erythropoietin production in individuals at doses exceeding 25 mg
CoCl2/day. Co has also been shown to exert effects on the thyroid gland, heart and nervous …

The association of cobalturia with cobaltism symptoms a prospective blinded study of 229 post-arthroplasty patients

SS Tower, BD Gessner, CS Cho, RL Bridges - Plos one, 2023 - journals.plos.org
Introduction Cobalt is a mitochondrial toxin, clinical cobaltism manifests with constitutional,
neurologic, and cardiovascular symptomatology. Cobalt's severe toxidrome is known …